UCSF

Tagged: Hydroxymethylglutaryl-CoA Reductase Inhibitors

Bani Tamraz, PharmD, PhD

Assistant Professor

My primary interest is identification of genetic determinants of drug response through modern methods aimed at addressing pharmacogenomics research and translating that information into new diagnostics and treatment strategies at point-of-care.

Brian Alldredge, PharmD

Vice Provost-Academic Affairs

My clinical practice and research focus on the drug treatment of epilepsy and the genetic, behavioral, and environmental factors that influence drug response.